This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeffers, M.
Right arrow Articles by Vande Woude, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeffers, M.
Right arrow Articles by Vande Woude, G. F.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Mar 1996, 1115-1125, Vol 16, No. 3
Copyright © 1996, American Society for Microbiology

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

M Jeffers, S Rong and GF Vande Woude
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Maryland 21702, USA.

Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector of cells expressing the Met tyrosine kinase receptor. Although HGF/SF is synthesized by mesenchymal cells and acts predominantly on epithelial cells, we have recently demonstrated that human sarcoma cell lines often inappropriately express high levels of Met and respond mitogenically to HGF/SF. In the present report we show that HGF/SF-Met signalling in the human leiomyosarcoma cell line SK-LMS-1 enhances its in vivo tumorigenicity, an effect for which the mitogenicity of this signalling pathway is likely to play a role. In addition, we found that HGF/SF-Met signalling dramatically induces the in vitro invasiveness and in vivo metastatic potential of these cells. We have studied the molecular basis by which HGFSF-Met signalling mediates the invasive phenotype. A strong correlation has previously been demonstrated between the activation of the urokinase plasminogen activator (uPA) proteolysis network and the acquisition of the invasive-metastatic phenotype, and we show here that HGF/SF-Met signalling significantly increases the protein levels of both uPA and its cellular receptor in SK-LMS-1 cells. This results in elevated levels of cell-associated uPA and enhanced plasmin-generating ability by these cells. These studies couple HGF/SF-Met signalling to the activation of proteases that mediate dissolution of the extracellular matrix-basement membrane, and important property for cellular invasion-metastasis.


This article has been cited by other articles:

  • Gao, C.-F., Xie, Q., Zhang, Y.-W., Su, Y., Zhao, P., Cao, B., Furge, K., Sun, J., Rex, K., Osgood, T., Coxon, A., Burgess, T. L., Vande Woude, G. F. (2009). Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma. Molecular Cancer Therapeutics 8: 2803-2810 [Abstract] [Full Text]  
  • Shanmukhappa, K., Matte, U., Degen, J. L., Bezerra, J. A. (2009). Plasmin-mediated Proteolysis Is Required for Hepatocyte Growth Factor Activation during Liver Repair. J. Biol. Chem. 284: 12917-12923 [Abstract] [Full Text]  
  • Liu, Y., Chattopadhyay, N., Qin, S., Szekeres, C., Vasylyeva, T., Mahoney, Z. X., Taglienti, M., Bates, C. M., Chapman, H. A., Miner, J. H., Kreidberg, J. A. (2009). Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis. Development 136: 843-853 [Abstract] [Full Text]  
  • Nakamura, K., Abarzua, F., Hongo, A., Kodama, J., Nasu, Y., Kumon, H., Hiramatsu, Y. (2009). Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer. Ann Oncol 20: 63-70 [Abstract] [Full Text]  
  • Zhao, P., Grabinski, T., Gao, C., Skinner, R. S., Giambernardi, T., Su, Y., Hudson, E., Resau, J., Gross, M., Vande Woude, G. F., Hay, R., Cao, B. (2007). Identification of a Met-Binding Peptide from a Phage Display Library. Clin. Cancer Res. 13: 6049-6055 [Abstract] [Full Text]  
  • Gao, C., Furge, K., Koeman, J., Dykema, K., Su, Y., Cutler, M. L., Werts, A., Haak, P., Vande Woude, G. F. (2007). Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc. Natl. Acad. Sci. USA 104: 8995-9000 [Abstract] [Full Text]  
  • Athauda, G., Giubellino, A., Coleman, J. A., Horak, C., Steeg, P. S., Lee, M.-J., Trepel, J., Wimberly, J., Sun, J., Coxon, A., Burgess, T. L., Bottaro, D. P. (2006). c-Met Ectodomain Shedding Rate Correlates with Malignant Potential.. Clin. Cancer Res. 12: 4154-4162 [Abstract] [Full Text]  
  • Kong-Beltran, M., Seshagiri, S., Zha, J., Zhu, W., Bhawe, K., Mendoza, N., Holcomb, T., Pujara, K., Stinson, J., Fu, L., Severin, C., Rangell, L., Schwall, R., Amler, L., Wickramasinghe, D., Yauch, R. (2006). Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer. Cancer Res. 66: 283-289 [Abstract] [Full Text]  
  • Hay, R. V., Cao, B., Skinner, R. S., Su, Y., Zhao, P., Gustafson, M. F., Qian, C.-N., Teh, B. T., Knudsen, B. S., Resau, J. H., Shen, S., Waters, D. J., Gross, M. D., Vande Woude, G. F. (2005). Nuclear Imaging of Met-Expressing Human and Canine Cancer Xenografts with Radiolabeled Monoclonal Antibodies (MetSeekTM). Clin. Cancer Res. 11: 7064s-7069s [Abstract] [Full Text]  
  • Gao, C.-F., Xie, Q., Su, Y.-L., Koeman, J., Khoo, S. K., Gustafson, M., Knudsen, B. S., Hay, R., Shinomiya, N., Woude, G. F. V. (2005). Proliferation and invasion: Plasticity in tumor cells. Proc. Natl. Acad. Sci. USA 102: 10528-10533 [Abstract] [Full Text]  
  • Li, H., Ye, X., Mahanivong, C., Bian, D., Chun, J., Huang, S. (2005). Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells. J. Biol. Chem. 280: 10564-10571 [Abstract] [Full Text]  
  • Hecht, M., Papoutsi, M., Tran, H. D., Wilting, J., Schweigerer, L. (2004). Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas. Cancer Res. 64: 6109-6118 [Abstract] [Full Text]  
  • Zhang, K.-X., Ward, K. R., Schrader, J. W. (2004). Multiple Aspects of the Phenotype of Mammary Epithelial Cells Transformed by Expression of Activated M-Ras Depend on an Autocrine Mechanism Mediated by Hepatocyte Growth Factor/Scatter Factor. Mol Cancer Res 2: 242-255 [Abstract] [Full Text]  
  • Hattori, N., Mizuno, S., Yoshida, Y., Chin, K., Mishima, M., Sisson, T. H., Simon, R. H., Nakamura, T., Miyake, M. (2004). The Plasminogen Activation System Reduces Fibrosis in the Lung by a Hepatocyte Growth Factor-Dependent Mechanism. Am. J. Pathol. 164: 1091-1098 [Abstract] [Full Text]  
  • Yoshida, S., Harada, T., Mitsunari, M., Iwabe, T., Sakamoto, Y., Tsukihara, S., Iba, Y., Horie, S., Terakawa, N. (2004). Hepatocyte Growth Factor/Met System Promotes Endometrial and Endometriotic Stromal Cell Invasion via Autocrine and Paracrine Pathways. J. Clin. Endocrinol. Metab. 89: 823-832 [Abstract] [Full Text]  
  • Shinomiya, N., Vande Woude, G. F. (2003). Suppression of Met Expression: A Possible Cancer Treatment: Commentary re: S. J. Kim et al., Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model. Clin. Cancer Res., 14: 5161-5170, 2003.. Clin. Cancer Res. 9: 5085-5090 [Full Text]  
  • Wang, X., Le, P., Liang, C., Chan, J., Kiewlich, D., Miller, T., Harris, D., Sun, L., Rice, A., Vasile, S., Blake, R. A., Howlett, A. R., Patel, N., McMahon, G., Lipson, K. E. (2003). Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Molecular Cancer Therapeutics 2: 1085-1092 [Abstract] [Full Text]  
  • Zhang, Y.-W., Su, Y., Volpert, O. V., Woude, G. F. V. (2003). Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100: 12718-12723 [Abstract] [Full Text]  
  • Ma, P. C., Kijima, T., Maulik, G., Fox, E. A., Sattler, M., Griffin, J. D., Johnson, B. E., Salgia, R. (2003). c-MET Mutational Analysis in Small Cell Lung Cancer: Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions. Cancer Res. 63: 6272-6281 [Abstract] [Full Text]  
  • Hay, R. V., Cao, B., Skinner, R. S., Wang, L.-M., Su, Y., Resau, J. H., Knudsen, B. S., Gustafson, M. F., Koo, H.-M., Woude, G. F. V., Gross, M. D. (2003). Radioimmunoscintigraphy of Human Met-Expressing Tumor Xenografts Using Met3, a New Monoclonal Antibody. Clin. Cancer Res. 9: 3839s-3844s [Abstract] [Full Text]  
  • Recio, J. A., Merlino, G. (2003). Hepatocyte Growth Factor/Scatter Factor Induces Feedback Up-Regulation of CD44v6 in Melanoma Cells through Egr-1. Cancer Res. 63: 1576-1582 [Abstract] [Full Text]  
  • Van Aken, E. H., De Wever, O., Van Hoorde, L., Bruyneel, E., De Laey, J.-J., Mareel, M. M. (2003). Invasion of Retinal Pigment Epithelial Cells: N-cadherin, Hepatocyte Growth Factor, and Focal Adhesion Kinase. IOVS 44: 463-472 [Abstract] [Full Text]  
  • Chan, P.-C., Liang, C.-C., Yu, K.-C., Chang, M.-C., Ho, W. L., Chen, B.-H., Chen, H.-C. (2002). Synergistic Effect of Focal Adhesion Kinase Overexpression and Hepatocyte Growth Factor Stimulation on Cell Transformation. J. Biol. Chem. 277: 50373-50379 [Abstract] [Full Text]  
  • Han, Q., Leng, J., Bian, D., Mahanivong, C., Carpenter, K. A., Pan, Z. K., Han, J., Huang, S. (2002). Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes Urokinase Plasminogen Activator mRNA Stability in Invasive Breast Cancer Cells. J. Biol. Chem. 277: 48379-48385 [Abstract] [Full Text]  
  • Taher, T. E. I., Tjin, E. P. M., Beuling, E. A., Borst, J., Spaargaren, M., Pals, S. T. (2002). c-Cbl Is Involved in Met Signaling in B Cells and Mediates Hepatocyte Growth Factor-Induced Receptor Ubiquitination. J. Immunol. 169: 3793-3800 [Abstract] [Full Text]  
  • Yu, Y., Merlino, G. (2002). Constitutive c-Met Signaling through a Nonautocrine Mechanism Promotes Metastasis in a Transgenic Transplantation Model. Cancer Res. 62: 2951-2956 [Abstract] [Full Text]  
  • Mildner, M., Eckhart, L., Lengauer, B., Tschachler, E. (2002). Hepatocyte Growth Factor/Scatter Factor Inhibits UVB-induced Apoptosis of Human Keratinocytes but Not of Keratinocyte-derived Cell Lines via the Phosphatidylinositol 3-Kinase/AKT Pathway. J. Biol. Chem. 277: 14146-14152 [Abstract] [Full Text]  
  • Providence, K. M., White, L. A., Tang, J., Gonclaves, J., Staiano-Coico, L., Higgins, P. J. (2002). Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene. J. Cell Sci. 115: 3767-3777 [Abstract] [Full Text]  
  • Tacchini, L., Dansi, P., Matteucci, E., Desiderio, M. A. (2001). Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22: 1363-1371 [Abstract] [Full Text]  
  • Cao, B., Su, Y., Oskarsson, M., Zhao, P., Kort, E. J., Fisher, R. J., Wang, L.-M., Vande Woude, G. F. (2001). Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. USA 98: 7443-7448 [Abstract] [Full Text]  
  • Shaharabany, M., Abramovitch, R., Kushnir, T., Tsarfaty, G., Ravid-Megido, M., Horev, J., Ron, R., Itzchak, Y., Tsarfaty, I. (2001). In Vivo Molecular Imaging of Met Tyrosine Kinase Growth Factor Receptor Activity in Normal Organs and Breast Tumors. Cancer Res. 61: 4873-4878 [Abstract] [Full Text]  
  • Kuo, C. J., LaMontagne, K. R. Jr., Garcia-Cardena, G., Ackley, B. D., Kalman, D., Park, S., Christofferson, R., Kamihara, J., Ding, Y.-H., Lo, K.-M., Gillies, S., Folkman, J., Mulligan, R. C., Javaherian, K. (2001). Oligomerization-Dependent Regulation of Motility and Morphogenesis by the Collagen Xviii Nc1/Endostatin Domain. JCB 152: 1233-1246 [Abstract] [Full Text]  
  • Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., Nakamura, T. (2000). HGF/NK4, a Four-Kringle Antagonist of Hepatocyte Growth Factor, Is an Angiogenesis Inhibitor that Suppresses Tumor Growth and Metastasis in Mice. Cancer Res. 60: 6737-6743 [Abstract] [Full Text]  
  • Wielenga, V. J. M., van der Voort, R., Taher, T. E. I., Smit, L., Beuling, E. A., van Krimpen, C., Spaargaren, M., Pals, S. T. (2000). Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer. Am. J. Pathol. 157: 1563-1573 [Abstract] [Full Text]  
  • Taniyama, Y., Morishita, R., Nakagami, H., Moriguchi, A., Sakonjo, H., Shokei-Kim, , Matsumoto, K., Nakamura, T., Higaki, J., Ogihara, T. (2000). Potential Contribution of a Novel Antifibrotic Factor, Hepatocyte Growth Factor, to Prevention of Myocardial Fibrosis by Angiotensin II Blockade in Cardiomyopathic Hamsters. Circulation 102: 246-252 [Abstract] [Full Text]  
  • Beilmann, M., Vande Woude, G. F., Dienes, H.-P., Schirmacher, P. (2000). Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 95: 3964-3969 [Abstract] [Full Text]  
  • Hanzawa, M., Shindoh, M., Higashino, F., Yasuda, M., Inoue, N., Hida, K., Ono, M., Kohgo, T., Nakamura, M., Notani, K.-i., Fukuda, H., Totsuka, Y., Yoshida, K., Fujinaga, K. (2000). Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21: 1079-1085 [Abstract] [Full Text]  
  • Otsuka, T., Jakubczak, J., Vieira, W., Bottaro, D. P., Breckenridge, D., Larochelle, W. J., Merlino, G. (2000). Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis. Mol. Cell. Biol. 20: 2055-2065 [Abstract] [Full Text]  
  • Taylor, G. A., Hudson, E., Resau, J. H., Vande Woude, G. F. (2000). Regulation of P311 Expression by Met-Hepatocyte Growth Factor/Scatter Factor and the Ubiquitin/Proteasome System. J. Biol. Chem. 275: 4215-4219 [Abstract] [Full Text]  
  • GIORDANO, S., MAFFE, A., WILLIAMS, T. A., ARTIGIANI, S., GUAL, P., BARDELLI, A., BASILICO, C., MICHIELI, P., COMOGLIO, P. M. (2000). Different point mutations in the met oncogene elicit distinct biological properties. FASEB J. 14: 399-406 [Abstract] [Full Text]  
  • Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M., Sausville, E., Monks, A., Vande Woude, G. F. (2000). The Geldanamycins Are Potent Inhibitors of the Hepatocyte Growth Factor/Scatter Factor-Met-Urokinase Plasminogen Activator-Plasmin Proteolytic Network. Cancer Res. 60: 342-349 [Abstract] [Full Text]  
  • Bardelli, A., Longati, P., Williams, T. A., Benvenuti, S., Comoglio, P. M. (1999). A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth. J. Biol. Chem. 274: 29274-29281 [Abstract] [Full Text]  
  • Koochekpour, S., Jeffers, M., Wang, P. H., Gong, C., Taylor, G. A., Roessler, L. M., Stearman, R., Vasselli, J. R., Stetler-Stevenson, W. G., Kaelin, W. G. Jr., Linehan, W. M., Klausner, R. D., Gnarra, J. R., Vande Woude, G. F. (1999). The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells. Mol. Cell. Biol. 19: 5902-5912 [Abstract] [Full Text]  
  • Ried, S., Jager, C., Jeffers, M., Vande Woude, G. F., Graeff, H., Schmitt, M., Lengyel, E. (1999). Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor. J. Biol. Chem. 274: 16377-16386 [Abstract] [Full Text]  
  • Morishita, R., Nakamura, S., Hayashi, S.-i., Taniyama, Y., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Takeshita, S., Matsumoto, K., Nakamura, T., Higaki, J., Ogihara, T. (1999). Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy. Hypertension 33: 1379-1384 [Abstract] [Full Text]  
  • Koo, H.-M., Gray-Goodrich, M., Kohlhagen, G., McWilliams, M. J., Jeffers, M., Vaigro-Wolff, A., Alvord, W. G., Monks, A., Paull, K. D., Pommier, Y., Vande Woude, G. F. (1999). The ras Oncogene-Mediated Sensitization of Human Cells to Topoisomerase II Inhibitor-Induced Apoptosis. JNCI J Natl Cancer Inst 91: 236-244 [Abstract] [Full Text]  
  • Rusciano, D, Lorenzoni, P, Burger, M. (1999). Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone. J. Cell Sci. 112: 623-630 [Abstract]  
  • Jeffers, M., Fiscella, M., Webb, C. P., Anver, M., Koochekpour, S., Vande Woude, G. F. (1998). The mutationally activated Met receptor mediates motility and metastasis. Proc. Natl. Acad. Sci. USA 95: 14417-14422 [Abstract] [Full Text]  
  • Chin, L., Merlino, G., DePinho, R. A. (1998). Malignant melanoma: modern black plague and genetic black box. Genes Dev. 12: 3467-3481 [Full Text]  
  • Trusolino, L., Serini, G., Cecchini, G., Besati, C., Ambesi-Impiombato, F. S., Marchisio, P. C., De Filippi, R. (1998). Growth Factor-dependent Activation of {alpha}v{beta}3 Integrin in Normal Epithelial Cells: Implications for Tumor Invasion. JCB 142: 1145-1156 [Abstract] [Full Text]  
  • Webb, C. P., Van Aelst, L., Wigler, M. H., Vande Woude, G. F. (1998). Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA 95: 8773-8778 [Abstract] [Full Text]  
  • Batlle, E., Verdu, J., Dominguez, D., Llosas, M. d. M., Diaz, V., Loukili, N., Paciucci, R., Alameda, F., de Herreros, A. G. (1998). Protein Kinase C-alpha Activity Inversely Modulates Invasion and Growth of Intestinal Cells. J. Biol. Chem. 273: 15091-15098 [Abstract] [Full Text]  
  • Lyon, M., Deakin, J. A., Rahmoune, H., Fernig, D. G., Nakamura, T., Gallagher, J. T. (1998). Hepatocyte Growth Factor/Scatter Factor Binds with High Affinity to Dermatan Sulfate. J. Biol. Chem. 273: 271-278 [Abstract] [Full Text]  
  • Prat, M, Crepaldi, T, Pennacchietti, S, Bussolino, F, Comoglio, P. (1998). Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. J. Cell Sci. 111: 237-247 [Abstract]  
  • Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., Vande Woude, G. F. (1997). Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA 94: 11445-11450 [Abstract] [Full Text]  
  • Lengyel, E., Wang, H., Stepp, E., Juarez, J., Wang, Y., Doe, W., Pfarr, C. M., Boyd, D. (1996). Requirement of an Upstream AP-1 Motif for the Constitutive and Phorbol Ester-inducible Expression of the Urokinase-type Plasminogen Activator Receptor Gene. J. Biol. Chem. 271: 23176-23184 [Abstract] [Full Text]  
  • Fournier, T. M., Kamikura, D., Teng, K., Park, M. (1996). Branching Tubulogenesis but Not Scatter of Madin-Darby Canine Kidney Cells Requires a Functional Grb2 Binding Site in the Met Receptor Tyrosine Kinase. J. Biol. Chem. 271: 22211-22217 [Abstract] [Full Text]  
  • Stefan, M., Koch, A., Mancini, A., Mohr, A., Weidner, K. M., Niemann, H., Tamura, T. (2001). Src Homology 2-containing Inositol 5-Phosphatase 1 Binds to the Multifunctional Docking Site of c-Met and Potentiates Hepatocyte Growth Factor-induced Branching Tubulogenesis. J. Biol. Chem. 276: 3017-3023 [Abstract] [Full Text]  
  • Atabey, N., Gao, Y., Yao, Z.-J., Breckenridge, D., Soon, L., Soriano, J. V., Burke, T. R. Jr., Bottaro, D. P. (2001). Potent Blockade of Hepatocyte Growth Factor-stimulated Cell Motility, Matrix Invasion and Branching Morphogenesis by Antagonists of Grb2 Src Homology 2 Domain Interactions. J. Biol. Chem. 276: 14308-14314 [Abstract] [Full Text]  
  • Duesbery, N. S., Resau, J., Webb, C. P., Koochekpour, S., Koo, H.-M., Leppla, S. H., Vande Woude, G. F. (2001). Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc. Natl. Acad. Sci. USA 98: 4089-4094 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»